Arbormed
PrivateLast Round
Private Placement
Apr 20, 2026
Est. Valuation
$51.16M
Total Funding Raised
$34.62M
Momentum Score
25 /100
Company Overview
Arbormed is a biopharmaceutical company that develops and commercializes therapeutics for diseases with high unmet medical needs, with a focus on rare diseases and complex generics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Pharma Supply Chain, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arbormed Comps
Public and private peers based on sector, stage, and business model.
Arbormed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Apr 20, 2026 | ||||
| Series C | Jul 1, 2024 | ||||
| Series B | Nov 1, 2021 | ||||
| Strategic | Jan 1, 2021 | ||||
| Series A | Jan 1, 2020 |
Arbormed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Series C |
| Aion Asset Management Co., Ltd. | Series A |
| SBI Investment Korea | Series C, Series A, Series B |
| Hana Securities Co., LTD | Series A |
| Korea Investment & Securities Co., Ltd. | Series C |
| 주식회사 브로드힐벤처스 | Series A |
| 코메스인베스트먼트 | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
$1.6M raised in a private placement round.
- Jun 1, 2025
Monthly visitors grew 111% MoM, reaching 2K.
Arbormed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arbormed's valuation, stock price, and market status.
